Biomimetic Therapeutics, Revenue Growth Rates (BMTI), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Biomimetic Therapeutics, Inc.  (BMTI)
 

BMTI's Revenue Growth by Quarter and Year

Biomimetic Therapeutics,'s Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BMTI Revenue (in millions $) FY 2012 FY 2011 FY 2010 FY 2009
4th Quarter December -
3rd Quarter September 0.69
2nd Quarter June 0.44
1st Quarter March 0.47
FY 1.60





BMTI Revenue third quarter 2012 Y/Y Growth Comment
Biomimetic Therapeutics, Inc. achieved in the third quarter 2012, above Company average Revenue rise of 60.15% year on year, to $ 0.69 millions.

Looking into third quarter 2012 results within Medical Equipment & Supplies industry 67 other companies have achieved higher Revenue growth. While Biomimetic Therapeutics, Inc.' s Revenue jump of 60.15% ranks overall at the positon no. 1787 in the third quarter 2012.


BMTI Revenue ( Y/Y Growth %) 2012
 2011 2010 2009
4th Quarter December - 31.43 % - -
3rd Quarter September 60.15 % 16.22 % - -
2nd Quarter June 0 % - - -
1st Quarter March 17.5 % - - -
FY   - 140.28 % - -

Financial Statements
Biomimetic Therapeutics,'s third quarter 2012 Revenue $ 0.69 millions BMTI's Income Statement
Biomimetic Therapeutics,'s third quarter 2011 Revenue $ 0.43 millions Quarterly BMTI's Income Statement


BMTI Revenue (Quarter on Quarter Growth %)

 2012
 2011 2010 2009
4th Quarter December - 6.98 % -5.41 % -
3rd Quarter September 56.51 % -2.27 % - -
2nd Quarter June -6.38 % 10 % - -
1st Quarter March 2.17 % 14.29 % - -
FY (Year on Year)   - 140.28 % - -


Back to BMTI Growth rate Comparisons >> Back to BMTI Growth rate Comparisons >>


Revenue third quarter 2012 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #68
Healthcare Sector #205
Overall #1787

Revenue Y/Y Growth Statistics
High Average Low
26.6 % 20.47 % 14.35 %
(Sep 30 2012)   (Jun 30 2012)
Revenue third quarter 2012 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #68
Healthcare Sector #205
Overall #1787
Revenue Y/Y Growth Statistics
High Average Low
26.6 % 20.47 % 14.35 %
(Sep 30 2012)   (Jun 30 2012)

Revenue by Quarter for the Fiscal Years 2009, 2010, 2011, 2012

Biomimetic Therapeutics,'s Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
57.56 % 25.64 % -6.28 %
(Sep 30 2012)  


BMTI's III. Quarter Q/Q Revenue Comment
Biomimetic Therapeutics, Inc. achieved in the III. Quarter 2012 above company average sequential Revenue jump of 56.51%, to $ 0.69 millions, from $0.44 millions in the second quarter.
BMTI is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Medical Equipment & Supplies industry 6 other companies have achieved higher Revenue quarter on quarter growth. While Biomimetic Therapeutics,'s Revenue growth quarter on quarter, overall rank is 160.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #7
Healthcare Sector #32
Overall #160
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #7
Healthcare Sector #32
Overall #160
Revenue Q/Q Growth Statistics
High Average Low
57.56 % 25.64 % -6.28 %
(Sep 30 2012)  


BMTI's III. Quarter Q/Q Revenue Comment
Biomimetic Therapeutics, Inc. achieved in the III. Quarter 2012 above company average sequential Revenue jump of 56.51%, to $ 0.69 millions, from $0.44 millions in the second quarter.
BMTI is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Medical Equipment & Supplies industry 6 other companies have achieved higher Revenue quarter on quarter growth. While Biomimetic Therapeutics,'s Revenue growth quarter on quarter, overall rank is 160.


Biomimetic Therapeutics,'s 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2012)		 12 Months Ending
(Jun 30 2012)		 12 Months Ending
(Mar 31 2012)		 12 Months Ending
(Dec 31 2011)		 12 Months Ending
Cumulative Revenue 12 Months Ending $ 2.05 $ 1.79 $ 0.00 $ 0.00 $ 0.00
Y / Y Revenue Growth (TTM) 26.6 % 14.35 % - - -
Year on Year Revenue Growth Overall Ranking # 825 # 0 # 0 # 0 # 0
Seqeuential Revenue Change (TTM) 14.53 % -0.12 % - - -
Seq. Revenue Growth (TTM) Overall Ranking # 1787 # 0 # 0 # 0 # 0


Cumulative Revenue growth Comment
With 26.6% annual Revenue growth, Biomimetic Therapeutics, Inc. would report a record annual Revenue rise if the fiscal year would end on Sep 30 2012.

In the Healthcare sector 115 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 825.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 68
Healthcare Sector # 116
Overall # 825

Revenue TTM Y/Y Growth Statistics
High Average Low
26.6 %
 20.47 %
14.35 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 68
Sector # 205
S&P 500 # 1787
Cumulative Revenue growth Comment
With 26.6% annual Revenue growth, Biomimetic Therapeutics, Inc. would report a record annual Revenue rise if the fiscal year would end on Sep 30 2012.

In the Healthcare sector 115 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 825.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 68
Healthcare Sector # 116
Overall # 825

Revenue TTM Y/Y Growth Statistics
High Average Low
26.6 %
20.47 %
14.35 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 68
Sector # 205
S&P 500 # 1787




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
BMTI's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue rise for the quarter ending Sep 30 2012 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2012
Lisata Therapeutics Inc 103.67%$ 103.673 millions
Vivosim Labs Inc 102.26%$ 102.258 millions
Assertio Holdings inc 101.44%$ 101.441 millions
Achari Ventures Holdings Corp I94.87%$ 94.872 millions
Therapeuticsmd Inc 92.08%$ 92.079 millions
Savient Pharmaceuticals Inc90.47%$ 90.469 millions
Akorn Inc89.72%$ 89.723 millions
Insite Vision Inc83.56%$ 83.563 millions
Repligen Corp74.99%$ 74.992 millions
Complete Genomics Inc74.19%$ 74.192 millions
Axogen inc 73.64%$ 73.637 millions
Opko Health Inc 73.28%$ 73.278 millions
Alkermes Plc 72.24%$ 72.244 millions
Palisade Bio Inc 65.22%$ 65.216 millions
Gadsden Properties, Inc.63.13%$ 63.134 millions
Immunogen inc 61.32%$ 61.317 millions
Biomimetic Therapeutics, Inc.60.68%$ 60.678 millions
Natus Medical Inc57.24%$ 57.240 millions
Ds Healthcare Group, Inc.54.71%$ 54.710 millions
Pacific Health Care Organization Inc53.49%$ 53.494 millions
Prestige Consumer Healthcare Inc 53.35%$ 53.353 millions
Grapefruit Usa Inc 52.37%$ 52.374 millions
Quantrx Biomedical Corporation51.13%$ 51.125 millions
Sangui Biotech International Inc50.00%$ 50.000 millions
Bolt Biotherapeutics Inc 49.06%$ 49.060 millions
Nephros Inc 48.40%$ 48.403 millions
Igc Pharma Inc 48.17%$ 48.171 millions
Bausch Health Companies Inc 47.21%$ 47.213 millions
Sorrento Therapeutics Inc 46.51%$ 46.514 millions
Antares Pharma Inc 45.09%$ 45.086 millions


About Biomimetic Therapeutics, Revenue Growth Rates (BMTI), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: the company’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.